Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 56 of the 56 references it cites were found in a registry or an index.

Probiotics for the Prevention of Clostridium difficile –Associated Diarrhea: A Systematic Review and Meta-analysis

Johnston, Bradley C., Ma, Stephanie S.Y., Goldenberg, Joshua Z., Thorlund, Kristian, Vandvik, Per O., Loeb, Mark, Guyatt, Gordon H. · 2012 · Annals of Internal Medicine

Abstract

BACKGROUND: Antibiotic treatment may disturb the resistance of gastrointestinal flora to colonization. This may result in complications, the most serious of which is Clostridium difficile–associated diarrhea (CDAD). PURPOSE: To assess the efficacy and safety of probiotics for the prevention of CDAD in adults and children receiving antibiotics. DATA SOURCES: Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL, Allied and Complementary Medicine Database, Web of Science, and 12 gray-literature sources. STUDY SELECTION: Randomized, controlled trials including adult or pediatric patients receiving antibiotics that compared any strain or dose of a specified probiotic with placebo or with no treatment control and reported the incidence of CDAD. DATA EXTRACTION: Two reviewers independently screened potentially eligible articles; extracted data on populations, interventions, and outcomes; and assessed risk of bias. The Grading of Recommendations Assessment, Development and Evaluation guidelines were used to independently rate overall confidence in effect estimates for each outcome. DATA SYNTHESIS: Twenty trials including 3818 participants met the eligibility criteria. Probiotics reduced the incidence of CDAD by 66% (pooled relative risk, 0.34 [95% CI, 0.24 to 0.49]; I(2) = 0%). In a population with a 5% incidence of antibiotic-associated CDAD (median control group risk), probiotic prophylaxis would prevent 33 episodes (CI, 25 to 38 episodes) per 1000 persons. Of probiotic-treated patients, 9.3% experienced adverse events, compared with 12.6% of control patients (relative risk, 0.82 [CI, 0.65 to 1.05]; I(2) = 17%). LIMITATIONS: In 13 trials, data on CDAD were missing for 5% to 45% of patients. The results were robust to worst-plausible assumptions regarding event rates in studies with missing outcome data. CONCLUSION: Moderate-quality evidence suggests that probiotic prophylaxis results in a large reduction in CDAD without an increase in clinically important adverse events. PRIMARY FUNDING SOURCE: None.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-157-12-201212180-00563

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Research works printed but not linked: 8

  1. 10.3201/eid1205.051064 · doi:10.3201/eid1205.051064 · Paper page
  2. Johnston BC, 2011, Cochrane Database Syst Rev, CD004827
  3. Can M, 2006, Med Sci Monit, 12, PI19
  4. McFarland LV, 1995, Am J Gastroenterol, 90, 439
  5. Plummer S, 2004, Int Microbiol, 7, 59
  6. Miller M, 2008, Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy, 48, 578
  7. Psaradellis E, 2010, Arch Med Sci, 6, 56
  8. Rafiq R, 2007, Gastroenterology, 132, A187

Cited by

See all 367

Metadata

Authors
Johnston, B. C., Ma, S. S. Y., Goldenberg, J. Z., Thorlund, K., Vandvik, P. O., Loeb, M., & Guyatt, G. H.
Affiliations
  • Bastyr University (US)
  • From The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada; Bastyr University, Kenmore, Washington; McMaster University, Hamilton, Ontario, Canada; and Innlandet Hospital Trust, Gjøvik, Norway.
Venue
Annals of Internal Medicine
Published
2012-12-18
Volume
157
Issue
12
Pages
878-888
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2088092352
Cited by
367
References
56
Citations by year
2026: 9 · 2025: 9 · 2024: 10 · 2023: 15 · 2022: 14 · 2021: 10 · 2020: 13 · 2019: 24 · 2018: 26 · 2017: 46 · 2016: 36 · 2015: 38 · 2014: 52 · 2013: 61 · 2012: 4
FWCI
6.15
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, Clostridium difficile-associated diarrhea, antibiotic-associated diarrhea, probiotic prophylaxis, antibiotic-induced dysbiosis, gut microbiota, adverse events, children, adults
MeSH terms
Adult, Anti-Bacterial Agents, Child, Diarrhea, Enterocolitis, Pseudomembranous, Humans, Risk Factors, Incidence, Clostridioides difficile, Probiotics, Gastrointestinal Tract

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Probiotics for the Prevention of Clostridium difficile –Associated Diarrhea: A Systematic Review and Meta-analysis. https://app.cochat.ai/papers/10.7326/0003-4819-157-12-201212180-00563
The paper
Johnston, B. C., Ma, S. S. Y., Goldenberg, J. Z., Thorlund, K., Vandvik, P. O., Loeb, M., & Guyatt, G. H. (2012). Probiotics for the Prevention of Clostridium difficile –Associated Diarrhea: A Systematic Review and Meta-analysis. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-157-12-201212180-00563

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.